Evidence map›Paper›PMID 31427580›Full record

ArticleNature communications2019

Author Correction: SREBP1 drives keratin-80-dependent cytoskeletal changes and invasive behavior in endocrine-resistant ERα breast cancer.

Ylenia Perone, Aaron J Farrugia, Alba Rodríguez-Meira, Balázs Győrffy, Charlotte Ion, Andrea Uggetti, Antonios Chronopoulos, Pasquale Marrazzo, Monica Faronato, Sami Shousha and 9 more

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 8 institutions in 4 countries.

Ylenia PeroneDepartment of Surgery and Cancer, Imperial College London, London, UK.ORCID http://orcid.org/0000-0002-6390-0327
Aaron J FarrugiaDivision of Cancer Biology, Tumour Microenvironment Team, Institute of Cancer Research, London, UK.
Alba Rodríguez-MeiraDepartment of Surgery and Cancer, Imperial College London, London, UK.
Balázs GyőrffyMTA TTK Lendület Cancer Biomarker Research Group, Institute of Enzymology, Hungarian Academy of Sciences, Budapest, Hungary.
Charlotte IonDepartment of Surgery and Cancer, Imperial College London, London, UK.
Andrea UggettiEuropean Institute of Oncology, Milan, Italy.
Antonios ChronopoulosFaculty of Engineering, Department of Bioengineering, Imperial College London, London, UK.
Pasquale MarrazzoDepartment for Life Quality Studies, Alma Mater Studiorum, University of Bologna, Rimini, Italy.ORCID http://orcid.org/0000-0001-6644-5828
Monica FaronatoDepartment of Chemistry, Imperial College London, London, UK.
Sami ShoushaHistopathology Department, Imperial College London, Charing Cross Hospital NHS Trust, London, UK.
Claire DaviesECMC Imperial College. Department of Surgery and Cancer, Imperial College London, London, UK.
Jennifer H SteelECMC Imperial College. Department of Surgery and Cancer, Imperial College London, London, UK.ORCID http://orcid.org/0000-0003-4439-0090
Naina PatelECMC Imperial College. Department of Surgery and Cancer, Imperial College London, London, UK.
Armando Del Rio HernandezFaculty of Engineering, Department of Bioengineering, Imperial College London, London, UK.ORCID http://orcid.org/0000-0001-5062-8910
Charles CoombesDepartment of Surgery and Cancer, Imperial College London, London, UK.
Giancarlo PruneriPathology Department, Fondazione IRCCS Istituto Nazionale Tumori and University of Milan, School of Medicine, Milan, Italy.
Adrian LimDepartment of Surgery and Cancer, Imperial College London, London, UK.
Fernando CalvoDivision of Cancer Biology, Tumour Microenvironment Team, Institute of Cancer Research, London, UK. calvof@unican.es.
Luca MagnaniDepartment of Surgery and Cancer, Imperial College London, London, UK. l.magnani@imperial.ac.uk.ORCID http://orcid.org/0000-0002-7534-0785
Imperial College London · GBInstitute of Cancer Research · GBCharing Cross Hospital · GBEuropean Institute of Oncology · ITMRC Weatherall Institute of Molecular Medicine · GBSemmelweis University · HUUniversity of Bologna · ITUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID31427580
PMCPMC6700086
OpenAlexW2969422584

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.